Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science

Share Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice

Sign up to save your podcasts

Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice

Keeping the Pace With Immunotherapy for First-Line NSCLC Treatment: Translating the Latest Evidence to Practice

More shows like PeerVoice Heart & Lung Video

PeerVoice Brain Behaviour Audio

PeerVoice Oncology & Haematology Audio

PeerVoice Oncology & Haematology Video

PeerVoice Endocrinology & Metabolic Disorders Audio

PeerVoice Digestive Diseases Audio

PeerVoice Digestive Diseases Video

PeerVoice Immunology & Infectious Disease Video

PeerVoice Immunology & Infectious Disease Audio

PeerVoice Internal Medicine Audio

PeerVoice Internal Medicine Video